246 related articles for article (PubMed ID: 11208881)
21. Dominant negative ATM mutations in breast cancer families.
Chenevix-Trench G; Spurdle AB; Gatei M; Kelly H; Marsh A; Chen X; Donn K; Cummings M; Nyholt D; Jenkins MA; Scott C; Pupo GM; Dörk T; Bendix R; Kirk J; Tucker K; McCredie MR; Hopper JL; Sambrook J; Mann GJ; Khanna KK
J Natl Cancer Inst; 2002 Feb; 94(3):205-15. PubMed ID: 11830610
[TBL] [Abstract][Full Text] [Related]
22. No evidence for constitutional ATM mutation in breast/gastric cancer families.
Bay JO; Grancho M; Pernin D; Presneau N; Rio P; Tchirkov A; Uhrhammer N; Verrelle P; Gatti RA; Bignon YJ
Int J Oncol; 1998 Jun; 12(6):1385-90. PubMed ID: 9592204
[TBL] [Abstract][Full Text] [Related]
23. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
24. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
[TBL] [Abstract][Full Text] [Related]
25. The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers.
Laitman Y; Boker-Keinan L; Berkenstadt M; Liphsitz I; Weissglas-Volkov D; Ries-Levavi L; Sarouk I; Pras E; Friedman E
Cancer Genet; 2016 Mar; 209(3):70-4. PubMed ID: 26778106
[TBL] [Abstract][Full Text] [Related]
26. [Ataxia telangiectasia: what impact in clinical oncology?].
Stoppa-Lyonnet D; Aurias A
Bull Cancer; 1992; 79(7):645-50. PubMed ID: 1467590
[TBL] [Abstract][Full Text] [Related]
27. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
[TBL] [Abstract][Full Text] [Related]
28. Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lymphopoietic neoplasms.
Waterhouse D; Carman WJ; Schottenfeld D; Gridley G; McLean S
Cancer; 1996 Feb; 77(4):763-70. PubMed ID: 8616770
[TBL] [Abstract][Full Text] [Related]
29. The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
Chen J; Birkholtz GG; Lindblom P; Rubio C; Lindblom A
Cancer Res; 1998 Apr; 58(7):1376-9. PubMed ID: 9537233
[TBL] [Abstract][Full Text] [Related]
30. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
[TBL] [Abstract][Full Text] [Related]
31. Malignant neoplasms in the families of patients with ataxia-telangiectasia.
Swift M; Sholman L; Perry M; Chase C
Cancer Res; 1976 Jan; 36(1):209-15. PubMed ID: 1248000
[TBL] [Abstract][Full Text] [Related]
32. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry.
Bernstein JL; Teraoka S; Southey MC; Jenkins MA; Andrulis IL; Knight JA; John EM; Lapinski R; Wolitzer AL; Whittemore AS; West D; Seminara D; Olson ER; Spurdle AB; Chenevix-Trench G; Giles GG; Hopper JL; Concannon P
Hum Mutat; 2006 Nov; 27(11):1122-8. PubMed ID: 16958054
[TBL] [Abstract][Full Text] [Related]
33. ATM mutations in cancer families.
Vorechovský I; Luo L; Lindblom A; Negrini M; Webster AD; Croce CM; Hammarström L
Cancer Res; 1996 Sep; 56(18):4130-3. PubMed ID: 8797579
[TBL] [Abstract][Full Text] [Related]
34. Occupational variation in the risk of female breast cancer in the Nordic countries.
Katuwal S; Martinsen JI; Kjaerheim K; Sparen P; Tryggvadottir L; Lynge E; Weiderpass E; Pukkala E
Cancer Causes Control; 2018 Nov; 29(11):1027-1038. PubMed ID: 30151565
[TBL] [Abstract][Full Text] [Related]
35. IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
Broeks A; Urbanus JH; de Knijff P; Devilee P; Nicke M; Klöpper K; Dörk T; Floore AN; van't Veer LJ
Hum Mutat; 2003 May; 21(5):521-8. PubMed ID: 12673794
[TBL] [Abstract][Full Text] [Related]
36. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.
Nichols KE; Levitz S; Shannon KE; Wahrer DC; Bell DW; Chang G; Hegde S; Neuberg D; Shafman T; Tarbell NJ; Mauch P; Ishioka C; Haber DA; Diller L
J Clin Oncol; 1999 Apr; 17(4):1259. PubMed ID: 10561187
[TBL] [Abstract][Full Text] [Related]
37. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH.
Jones N; Vogt S; Nielsen M; Christian D; Wark PA; Eccles D; Edwards E; Evans DG; Maher ER; Vasen HF; Hes FJ; Aretz S; Sampson JR
Gastroenterology; 2009 Aug; 137(2):489-94, 494.e1; quiz 725-6. PubMed ID: 19394335
[TBL] [Abstract][Full Text] [Related]
38. Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study.
Winther JF; Sankila R; Boice JD; Tulinius H; Bautz A; Barlow L; Glattre E; Langmark F; Möller TR; Mulvihill JJ; Olafsdottir GH; Ritvanen A; Olsen JH
Lancet; 2001 Sep; 358(9283):711-7. PubMed ID: 11551577
[TBL] [Abstract][Full Text] [Related]
39. Cancer risks in BRCA2 mutation carriers.
Breast Cancer Linkage Consortium
J Natl Cancer Inst; 1999 Aug; 91(15):1310-6. PubMed ID: 10433620
[TBL] [Abstract][Full Text] [Related]
40. Cancer predisposition of ataxia-telangiectasia heterozygotes.
Swift M; Chase CL; Morrell D
Cancer Genet Cytogenet; 1990 May; 46(1):21-7. PubMed ID: 2184933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
